# Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients

> **NCT01437943** · PHASE4 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Kidney Disease
- Kidney Failure, Chronic

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01437943
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Novartis has have decided to terminate all clinical investigator-initiated research projects involving aliskiren
- **Last updated:** 2017-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437943, "Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01437943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*